Welcome • User Guide
ToS • Privacy • Canary
Donate • Bugs • License

©2025 Poal.co

532

One, Two, Three, Dead.

https://apnews.com/article/business-health-coronavirus-pandemic-c7c6de905cd614d66cdf727dda661c5a

"Those agencies, though, are awaiting critical data [like how many purebloods there still are?] before signing off on the third doses, with Moderna’s vaccine increasingly seen as unlikely to make the Sept. 20 milestone."

"According to one official, Moderna produced inadequate data for the FDA and CDC to recommend the third dose of its vaccine and FDA has requested additional data that is likely to delay those boosters into October. Pfizer, which is further along in the review process, in part because of data collected from the vaccine’s use in Israel, is still expected to be approved for a third dose for all by Sept. 20. A key FDA panel is to review Pfizer’s data on boosters on Sept. 17."

Cohencidentally, October is when many mandates take place, also when the booster may be delayed until. Convenient.

One, Two, Three, Dead. https://apnews.com/article/business-health-coronavirus-pandemic-c7c6de905cd614d66cdf727dda661c5a "Those agencies, though, are awaiting critical data [*like how many purebloods there still are?*] before signing off on the third doses, with Moderna’s vaccine increasingly seen as unlikely to make the Sept. 20 milestone." "According to one official, Moderna produced inadequate data for the FDA and CDC to recommend the third dose of its vaccine and FDA has requested additional data that is **likely to delay those boosters into October.** Pfizer, which is further along in the review process, in part because of data collected from the vaccine’s use in Israel, is still expected to be approved for a third dose for all by Sept. 20. A key FDA panel is to review Pfizer’s data on boosters on Sept. 17." Cohencidentally, October is when many mandates take place, also when the booster may be delayed until. Convenient.

(post is archived)

You are currently inside a comment thread.
Click here to see all the comments (11).
[–] • 0 pt (edited )

The FDA just had their review of the booster and they don't recommended it for people below 65.

The Biden admin would have a weird time getting around the FDA so quickly.

Instead of booster, since they are obviously failing in Israel, I suspect that they will have yearly Flu-Covid shot that target the new strain. I think there would be less pushback against that since it doesn't look like the shot is shit, it looks like business as usual (flu wise).

[–] • 0 pt
[–] • 0 pt

When does the FDA recommend drugs?

Is that a thing?

[–] • 0 pt

At least in this instance they did a risk-benefit analysis.